08/17/2026 | Press release | Distributed by Public on 08/17/2026 14:37
|
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | |||
|
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Rights | (2) | (2) | Ordinary Shares | 33,400(2) | (2) | I(2) | By Pelican II Capital Solutions Limited |
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Labbe Robert L. C/O PELICAN ACQUISITION II CORPORATION, 1185 6TH AVE., SUITE 349 NEW YORK, NY 10036 |
X | X | Chairman, CEO and CFO | |
| /s/ Robert Labbe | 08/17/2026 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | The securities reported herein are held directly by Pelican II Capital Solutions Limited (the "Sponsor"). Mr. Robert Labbe, as the managing member of the Sponsor, has sole voting and dispositive power over the securities held by the Sponsor. As a result of the underwriter's full exercise of its over-allotment option to purchase 1,125,000 units on July 27, 2026, no such shares are subject to forfeiture. Also includes 334,000 ordinary shares underlying the private placement units sold in a private placement conducted simultaneously with the Issuer's initial public offering. |
| (2) | Includes 334,000 rights underlying the private placement units, which were sold in a private placement taking place simultaneously with the Issuer's initial public offering. Each right is exchangeable for one-tenth of one ordinary share. |